Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

315
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
315
Seizures: Classification01:13

Seizures: Classification

631
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
631
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

289
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
289
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

736
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
736
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

35.4K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
35.4K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

307
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
307

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Examining Epilepsy in Angelman Syndrome: Insights From Caregiver-Reported Data in the Linking Angelman and Dup15q Data for Expanded Research Database.

Pediatric neurology·2026
Same author

Long-term safety and efficacy of deoxycytidine/deoxythymidine in treatment of POLG-related disorders.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Education Research: Defining Competencies and Consensus in Canadian Epilepsy Fellowship Training: A Thematic Discourse Analysis of Expert Perspectives.

Neurology. Education·2026
Same author

Management of ring chromosome 20 syndrome: Narrative review and consensus recommendations.

Epilepsia·2026
Same author

Preparation and Assembly of the Axial Invasion Chamber for Live-Cell Invadopodia Imaging.

Bio-protocol·2026
Same author

Self-limited neonatal epilepsy with 2q24.3 duplications: Case series and literature review.

Epileptic disorders : international epilepsy journal with videotape·2026
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Sep 27, 2025

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

561

Genetic Epilepsy Syndromes.

Kenneth A Myers

    Continuum (Minneapolis, Minn.)
    |April 8, 2022
    PubMed
    Summary
    This summary is machine-generated.

    This review covers common genetic epilepsy syndromes, detailing their clinical features, EEG findings, and molecular causes. Advances in understanding genetic epilepsy offer new precision medicine treatments, potentially improving patient outcomes.

    More Related Videos

    A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
    06:58

    A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

    Published on: July 12, 2021

    5.1K
    Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy
    08:26

    Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy

    Published on: October 19, 2021

    5.8K

    Related Experiment Videos

    Last Updated: Sep 27, 2025

    Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
    08:04

    Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

    Published on: June 6, 2025

    561
    A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
    06:58

    A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

    Published on: July 12, 2021

    5.1K
    Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy
    08:26

    Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy

    Published on: October 19, 2021

    5.8K

    Area of Science:

    • Neurology
    • Genetics
    • Epileptology

    Background:

    • Genetic factors are increasingly recognized as significant contributors to various epilepsy syndromes.
    • Understanding these genetic underpinnings is crucial for accurate diagnosis and effective management.

    Purpose of the Study:

    • To review common genetic epilepsy syndromes, including their clinical presentations, electroencephalogram (EEG) findings, and molecular etiologies.
    • To discuss emerging therapies and the impact of precision medicine on prognosis for these conditions.

    Main Methods:

    • Literature review of clinical features, EEG findings, treatment, prognosis, and molecular causes of common genetic epilepsy syndromes.
    • Discussion of specific syndromes such as genetic generalized epilepsy, developmental and epileptic encephalopathies, and familial epilepsy syndromes.

    Main Results:

    • Significant advances have been made in identifying genetic factors responsible for epilepsy syndromes.
    • New precision medicine therapies are becoming available, offering potential for improved prognoses in select cases.

    Conclusions:

    • Accurate identification of electroclinical syndromes is essential for neurologists, especially pediatric specialists.
    • Proper diagnosis guides appropriate treatment selection, prognosis counseling, and management of comorbidities.